Goldman Sachs’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.24M | Sell |
|
|||||
|
2025
Q1 | $8.92M | Sell |
|
|||||
|
2024
Q4 | $11.9M | Buy |
|
|||||
|
2024
Q3 | $9.53M | Buy |
|
|||||
|
2024
Q2 | $5.44M | Buy |
|
|||||
|
2024
Q1 | $4.17M | Sell |
|
|||||
|
2023
Q4 | $4.56M | Sell |
|
|||||
|
2023
Q3 | $4.18M | Sell |
|
|||||
|
2023
Q2 | $7.7M | Buy |
|
|||||
|
2023
Q1 | $4.56M | Buy |
|
|||||
|
2022
Q4 | $4.12M | Buy |
|
|||||
|
2022
Q3 | $3.08M | Sell |
|
|||||
|
2022
Q2 | $3.88M | Sell |
|
|||||
|
2022
Q1 | $6.06M | Sell |
|
|||||
|
2021
Q4 | $13.6M | Buy |
|
|||||
|
2021
Q3 | $8.41M | Sell |
|
|||||
|
2021
Q2 | $12.8M | Sell |
|
|||||
|
2021
Q1 | $20.4M | Sell |
|
|||||
|
2020
Q4 | $26.7M | Buy |
|
|||||
|
2020
Q3 | $9.87M | Sell |
|
|||||
|
2020
Q2 | $12.6M | Sell |
|
|||||
|
2020
Q1 | $8.54M | Sell |
|
|||||
|
2019
Q4 | $14.1M | Buy |
|
|||||
|
2019
Q3 | $9.99M | Sell |
|
|||||
|
2019
Q2 | $34.7M | Sell |
|
|||||
|
2019
Q1 | $47.3M | Buy |
|
|||||
|
2018
Q4 | $40.8M | Buy |
|
|||||
|
2018
Q3 | $61.5M | Sell |
|
|||||
|
2018
Q2 | $76.4M | Buy |
|
|||||
|
2018
Q1 | $44M | Buy |
|
|||||
|
2017
Q4 | $30.4M | Sell |
|
|||||
|
2017
Q3 | $36.2M | Sell |
|
|||||
|
2017
Q2 | $33.3M | Buy |
|
|||||
|
2017
Q1 | $25.6M | Buy |
|
|||||
|
2016
Q4 | $17.2M | Sell |
|
|||||
|
2016
Q3 | $22.5M | Buy |
|
|||||
|
2016
Q2 | $3.7M | Buy |
|
|||||
|
2016
Q1 | $2.35M | Buy |
|
|||||
|
2015
Q4 | $977K | Sell |
|
|||||
|
2015
Q3 | $3.22M | Sell |
|
|||||
|
2015
Q2 | $9.31M | Sell |
|
|||||
|
2015
Q1 | $28.4M | Buy |
|
|||||
|
2014
Q4 | $11M | Sell |
|
|||||
|
2014
Q3 | $10.1M | Buy |
|
|||||
|
2014
Q2 | $12.5M | Buy |
|
|||||
|
2014
Q1 | $8.54M | Sell |
|
|||||
|
2013
Q4 | $8.15M | Buy |
|
|||||
|
2013
Q3 | $3.38M | Buy |
|
|||||
|
2013
Q2 | $2.57M | Buy |
|